
Katherine A. Will
Examiner (ID: 13366, Phone: (571)270-0516 , Office: P/1747 )
| Most Active Art Unit | 1747 |
| Art Unit(s) | 1747, 1779 |
| Total Applications | 491 |
| Issued Applications | 285 |
| Pending Applications | 79 |
| Abandoned Applications | 153 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6390496
[patent_doc_number] => 20100317917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/825853
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10460
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317917.pdf
[firstpage_image] =>[orig_patent_app_number] => 12825853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/825853 | FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES | Jun 28, 2010 | Abandoned |
Array
(
[id] => 8300919
[patent_doc_number] => 20120183477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Therapeutic Antibody Target Validation and Screening In Vivo'
[patent_app_type] => utility
[patent_app_number] => 13/378318
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20358
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378318
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/378318 | Therapeutic Antibody Target Validation and Screening In Vivo | Jun 24, 2010 | Abandoned |
Array
(
[id] => 6292792
[patent_doc_number] => 20100239615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/795460
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77110
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239615.pdf
[firstpage_image] =>[orig_patent_app_number] => 12795460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/795460 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER | Jun 6, 2010 | Abandoned |
Array
(
[id] => 9311828
[patent_doc_number] => 08653046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Controlling transgene expression across the skin'
[patent_app_type] => utility
[patent_app_number] => 13/263149
[patent_app_country] => US
[patent_app_date] => 2010-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 8724
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263149
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/263149 | Controlling transgene expression across the skin | Mar 31, 2010 | Issued |
Array
(
[id] => 8227234
[patent_doc_number] => 20120141440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'FOAMYVIRUS VECTORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/259190
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9706
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/259190 | FOAMYVIRUS VECTORS AND METHODS OF USE | Mar 25, 2010 | Abandoned |
Array
(
[id] => 8138443
[patent_doc_number] => 20120093775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/260654
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 31205
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093775.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260654 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS | Mar 25, 2010 | Abandoned |
Array
(
[id] => 8336279
[patent_doc_number] => 20120202985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon'
[patent_app_type] => utility
[patent_app_number] => 13/255226
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18647
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255226
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255226 | Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon | Feb 25, 2010 | Abandoned |
Array
(
[id] => 7657290
[patent_doc_number] => 20110306559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/646725
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25260
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12646725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/646725 | METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN | Dec 22, 2009 | Abandoned |
Array
(
[id] => 7513003
[patent_doc_number] => 20110258713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/141326
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9452
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20110258713.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141326
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141326 | COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION | Dec 22, 2009 | Abandoned |
Array
(
[id] => 7491169
[patent_doc_number] => 20110252486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/140164
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14349
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20110252486.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140164 | CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME | Dec 17, 2009 | Abandoned |
Array
(
[id] => 7504204
[patent_doc_number] => 20110265194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/126344
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9716
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20110265194.pdf
[firstpage_image] =>[orig_patent_app_number] => 13126344
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126344 | THEM5-MODIFIED MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE | Oct 28, 2009 | Abandoned |
Array
(
[id] => 6182734
[patent_doc_number] => 20110179505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM'
[patent_app_type] => utility
[patent_app_number] => 13/121202
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 27685
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20110179505.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121202 | RODENT CANCER MODEL FOR HUMAN FGFR4 ARG388 POLYMORPHISM | Sep 28, 2009 | Abandoned |
Array
(
[id] => 7500557
[patent_doc_number] => 20110263015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR GENERATION OF PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/059951
[patent_app_country] => US
[patent_app_date] => 2009-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15816
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263015.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059951 | COMPOSITIONS AND METHODS FOR GENERATION OF PLURIPOTENT STEM CELLS | Aug 19, 2009 | Abandoned |
Array
(
[id] => 8064929
[patent_doc_number] => 20110244575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP)'
[patent_app_type] => utility
[patent_app_number] => 13/055138
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 51014
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20110244575.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055138
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055138 | METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP) | Jul 22, 2009 | Abandoned |
Array
(
[id] => 8504909
[patent_doc_number] => 20120304317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'TRANSGENIC RODENT EXPRESSING TRUNCATED DISC1'
[patent_app_type] => utility
[patent_app_number] => 13/054444
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 16624
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054444
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054444 | TRANSGENIC RODENT EXPRESSING TRUNCATED DISC1 | Jul 15, 2009 | Abandoned |
Array
(
[id] => 9503296
[patent_doc_number] => 08741607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'HCV/GBV-B chimeric virus'
[patent_app_type] => utility
[patent_app_number] => 13/054356
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14511
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054356
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054356 | HCV/GBV-B chimeric virus | Jul 14, 2009 | Issued |
Array
(
[id] => 7653396
[patent_doc_number] => 20110302665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'NON-HUMAN MAMMALS WITH T OR B CELLS HAVING PREDEFINED SPECIFICITY'
[patent_app_type] => utility
[patent_app_number] => 13/002334
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 27053
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0302/20110302665.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002334 | NON-HUMAN MAMMALS WITH T OR B CELLS HAVING PREDEFINED SPECIFICITY | Jul 1, 2009 | Abandoned |
Array
(
[id] => 8138437
[patent_doc_number] => 20120093772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/993092
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17950
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093772.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993092 | VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE | May 19, 2009 | Abandoned |
Array
(
[id] => 5495334
[patent_doc_number] => 20090263362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/412810
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18341
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263362.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412810 | FERTILITY ENHANCEMENT USING LIPID CARRIERS AND BIOACTIVE MOLECULES | Mar 26, 2009 | Abandoned |
Array
(
[id] => 6134393
[patent_doc_number] => 20110008295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SIMIAN ADENOVIRUSES SADV-36, -42.1, -42.2, AND -44 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/920648
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21057
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008295.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920648
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920648 | Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof | Mar 2, 2009 | Issued |